231
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Effects of Exercise Therapy Alone and in Combination with a Calcium Channel Blocker or an Angiotensin Receptor Blocker in Hypertensive Patients

, , &
Pages 523-529 | Received 06 Dec 2011, Accepted 10 Feb 2012, Published online: 04 May 2012

REFERENCES

  • Ogihara T, Kikuchi K, Matsuoka H, . The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009; 32:3–107.
  • Thijssen DH, Maiorana AJ, O’Driscoll G, Cable NT, Hopman MT, Green DJ. Impact of inactivity and exercise on the vasculature in humans. Eur J Appl Physiol 2010; 108:845–875.
  • Ogihara T, Nakao K, Fukui T, . Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial. Hypertension 2008; 51:393–398.
  • Mochizuki S, Dahlof B, Shimizu M, . Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei heart study): a randomised, open-label, blinded endpoint morbidity-mortality study. Lancet 2007; 369:1431–1439.
  • Kumahara H, Schutz Y, Ayabe M, . The use of uniaxial accelerometry for the assessment of physical-activity-related energy expenditure: a validation study against whole-body indirect calorimetry. Br J Nutr 2004; 91:235–243.
  • Fagard RH. Effects of exercise, diet and their combination on blood pressure. J Hum Hypertens 2005; 19(Suppl 3):S20–S24.
  • Papadopoulos DP, Makris TK, Papademetriou V. Is it time to treat prehypertension? Hypertens Res 2008; 31:1681–1686.
  • Kiyonaga A, Arakawa K, Tanaka H, Shindo M. Blood pressure and hormonal responses to aerobic exercise. Hypertension 1985; 7:125–131.
  • Hanefeld M, Abletshauser C. Effect of the angiotensin ii receptor antagonist valsartan on lipid profile and glucose metabolism in patients with hypertension. J Int Med Res 2001; 29:270–279.
  • Kintscher U, Marx N, Martus P, . Effect of high-dose valsartan on inflammatory and lipid parameters in patients with type 2 diabetes and hypertension. Diabetes Res Clin Pract 2010; 89:209–215.
  • Derosa G, Cicero AF, Bertone G, . Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, double-blind study. Clin Ther 2004; 26:1228–1236.
  • Inoue T, Taguchi I, Abe S, Toyoda S, Sakuma M, Node K. Inhibition of intestinal cholesterol absorption might explain cholesterol-lowering effect of telmisartan. J Clin Pharm Ther 2011; 36:103–110.
  • Sacristan D, Marques M, Zamorano-Leon JJ, . Modifications by olmesartanmedoxomil treatment of the platelet protein profile of moderate hypertensive patients. Proteomics Clin Appl 2008; 2:1300–1312.
  • Kyvelou SM, Vyssoulis GP, Karpanou EA, . Effects of antihypertensive treatment with angiotensin II receptor blockers on lipid profile: an open multi-drug comparison trial. Hellenic J Cardiol 2006; 47:21–28.
  • Benson SC, Pershadsingh HA, Ho CI, . Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity. Hypertension 2004; 43:993–1002.
  • Hirano T, Ran J, Adachi M. Opposing actions of angiotensin II type 1 and 2 receptors on plasma cholesterol levels in rats. J Hypertens 2006; 24:103–108.
  • Ciampone S, Borges R, de Lima IP, Mesquita FF, Cambiucci EC, Gontijo JA. Long-term exercise attenuates blood pressure responsiveness and modulates kidney angiotensin II signalling and urinary sodium excretion in SHR. J Renin Angiotensin Aldosterone Syst 2011; 12:394–403.
  • Pereira MG, Ferreira JC, Bueno CR, Jr., . Exercise training reduces cardiac angiotensin II levels and prevents cardiac dysfunction in a genetic model of sympathetic hyperactivity-induced heart failure in mice. Eur J Appl Physiol 2009; 105:843–850.
  • Block LH, Matthys H, Emmons LR, Perruchoud A, Erne P, Roth M. Ca(2+)-channel blockers modulate expression of 3-hydroxy-3-methylglutaryl-coenzyme a reductase and low density lipoprotein receptor genes stimulated by platelet-derived growth factor. Proc Natl Acad Sci USA 1991; 88:9041–9045.
  • Kramsch DM. Limits of lipid-lowering therapy: the potential benefits of amlodipine as an antiatherosclerotic agent. Int J Cardiol 1997; 62(Suppl 2):S119–S124.
  • Ji LL. Exercise-induced modulation of antioxidant defense. Ann N Y Acad Sci 2002; 959:82–92.
  • van der Zijl NJ, Moors CC, Goossens GH, Hermans MM, Blaak EE, Diamant M. Valsartan improves {beta}-cell function and insulin sensitivity in subjects with impaired glucose metabolism: a randomized controlled trial. Diabetes Care 2011; 34:845–851.
  • Suksomboon N, Poolsup N, Prasit T. Systematic review of the effect of telmisartan on insulin sensitivity in hypertensive patients with insulin resistance or diabetes. J Clin Pharm Ther 2011; 17:1365–2710.
  • Guo Q, Minami N, Mori N, . Effects of antihypertensive drugs and exercise training on insulin sensitivity in spontaneously hypertensive rats. Hypertens Res 2008; 31:525–533.
  • Shaw K, Gennat H, O’Rourke P, Del Mar C. Exercise for overweight or obesity. Cochrane Database Syst Rev 2006; 18:CD003817.
  • Villareal DT, Chode S, Parimi N, . Weight loss, exercise, or both and physical function in obese older adults. N Engl J Med 2011; 364:1218–1229.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.